ARI-3037MO
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ARI-3037MO, covering 2016-08-08 to 2016-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia [Phase 2]